Market Research Logo

In Vitro Diagnostics (IVD) Global Market - Forecast to 2023

In Vitro Diagnostics (IVD) Global Market - Forecast to 2023

In-vitro diagnostic is a process in which reagents, instruments, and systems are intended for the diagnosis of disease or other conditions or for determining the state of health, to cure, mitigate, treat, or prevent disease. This includes reagents, calibrators, control materials, specimen receptacles, software, and related instruments.

The in-vitro diagnostics market is segmented into Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Rapid tests, Enzyme-Linked Immunospot (Elispot) Assay and others are some of the immunoassay techniques in the IVD market. Basic Metabolic Panel, Electrolyte Panel, liver Panel, Lipid Profile, Renal Profile and Thyroid function panel and specialty chemical tests are some of the clinical chemistry technologies. Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Microarray, Hybridization, DNA Sequencing & Next-Generation Sequencing and others are some of the molecular diagnostics market. Along with these, clinical microbiology, hematology, coagulation and hemostasis and others are the type of the IVD technologies in the market.

Among technologies in in-vitro diagnostics market, immunochemistry techniques accounted for the largest share in 2016 growing at mid range single digit CAGR and molecular diagnostics is expected to grow at high single digit CAGR from 2016-2023.

By application, the in-vitro diagnostics global market is segmented into oncology, diabetes, cardiology, nephrology, transplantation technology, genetic testing, autoimmune diseases, drug testing, infectious diseases and others. Infectious diseases held the largest revenue in 2016 and transplantation diagnostics application is expected to grow at double digit CAGR from 2016-2023.

By product type, the market is segmented into reagents, instruments, software and services. The reagents segment accounted for the largest revenue in 2016, and is expected to grow at mid range single digit CAGR from 2016 to 2023.

By sample type, the market is segmented into blood, urine, saliva and others. The blood segment accounted for the largest revenue in 2016, and is expected to grow at mid range single digit CAGR from 2016 to 2023.

By end-users, the market is segmented into laboratories, hospitals, academic, and home care. The hospitals end user segment accounted for the largest revenue in 2016, home healthcare is fastest growing segment during the forecasting period.

By geography, the market is segmented into North America, Europe, Asia-Pacific and Rest of World. North America holds the largest market share in 2016, followed by Europe and Asia. The APAC regions tend to be an emerging market with an opportunity for growth with a highest CAGR from 2016-2023 and are likely to be a destination of investment for new investors in the in-vitro diagnosis market.

Growing healthcare expenditure in the emerging markets, strong demand for technologically advanced testing methods for disease diagnosis, increasing adaptation of point of care testing, increasing incidences of chronic lifestyle diseases are some of the important driving factors for this market. It is also seen that there is an increase in the number of clinical laboratories with improved infrastructure in many developed countries which could further push the diagnostics market in these regions. However, Lack of proper reimbursement policies in the developing countries and stringent regulatory framework are the main factors hampering the growth of the IVD market.

The in-vitro diagnostics global market is a competitive and all the active players in this market are involved in innovating new and advanced products to maintain their market shares. The key players in the in-vitro diagnostics global market include Abbott Laboratories (U.S.), Becton Dickinson (U.S.), Bio-Rad laboratories (U.S.), BioMerieux (France), Danaher Corporation (U.S.), Hoffmann-la Roche (Switzerland), Siemens AG (Germany), Carlyle Group (Ortho Clinical Diagnostics) (U.S.), Johnson and Johnson (U.S.), Sysmex Corporation (Japan), ThermoFisher Scientific (U.S.), and Hologic Inc (U.S.).

The report provides an in depth market analysis of the above mentioned segments across the following regions:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)


1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN & DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.5 PRIMARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Growing incidence of chronic and infectious diseases
3.3.1.2 Increasing adoption of point-of-care testing
3.3.1.3 Emergence of next generation molecular diagnostics
3.3.1.4 Growing awareness of companion diagnostics and personalized
medicine
3.3.1.5 Emergence of minimally invasive and non invasive diagnostics
3.3.1.6 Rising number of clia-waived ivd tests
3.3.2 RESTRAINTS & THREATS
3.3.2.1 Rising incidence of product recalls
3.3.2.2 Lack of skilled laboratory technicians in developing nations
3.3.2.3 Inadequate reimbursement
3.3.2.4 Stringent regulatory framework
3.4 PORTER’S FIVE FORCE ANALYSIS
3.4.1 THREAT OF NEW ENTRANTS
3.4.2 THREAT OF SUBSTITUTES
3.4.3 BARGAINING POWER OF SUPPLIERS
3.4.4 BARGAINING POWER OF BUYERS
3.4.5 RIVALRY AMONG EXISTING COMPETITORS
3.5 REGULATORY AFFAIRS
3.6 TECHNOLOGICAL ADVANCEMENTS
3.7 FUNDING SCENARIO
3.8 SUPPLY CHAIN ANALYSIS
3.9 MARKET SHARE ANALYSIS BY IN-VITRO DIAGNOSTICS MAJOR
PLAYERS
3.9.1 MARKET SHARE ANALYSIS BY IMMUNOASSAY IN-VITRO DIAGNOSTICS MAJOR PLAYERS
3.9.2 MARKET SHARE ANALYSIS BY CLINICAL CHEMISTRY IN-VITRO DIAGNOSTICS MAJOR PLAYERS
3.9.3 MARKET SHARE ANALYSIS BY MOLECULAR DIAGNOSTICS
MAJOR PLAYERS
3.9.4 MARKET SHARE ANALYSIS BY CLINICAL MICROBIOLOGY IN-VITRO DIAGNOSTICS MAJOR PLAYERS
3.9.5 MARKET SHARE ANALYSIS BY HEMATOLOGY IN-VITRO DIAGNOSTICS MAJOR PLAYERS
3.9.6 MARKET SHARE ANALYSIS BY COAGULATION AND HEMOSTASIS
IN-VITRO DIAGNOSTICS MAJOR PLAYERS
4 IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY TECHNOLOGY
4.1 INTRODUCTION
4.2 IMMUNOCHEMISTRY
4.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAYS (ELISA)
4.2.1.1 Chemiluminescence Immunoassays (CLIAS)
4.2.1.2 Fluorescence Immunoassays (FIAS)
4.2.1.3 Colorimetric Immunoassays (CIS)
4.2.2 RADIOIMMUNOASSAY (RIA)
4.2.3 ENZYME-LINKED IMMUNOSPOT (ELISPOT) ASSAY
4.2.4 RAPID TESTS
4.2.5 OTHER IMMUNOASSAY TECHNIQUES
4.3 CLINICAL CHEMISTRY
4.3.1 BASIC METABOLIC PROFILE
4.3.2 ELECTROLYTE PANEL
4.3.3 LIVER PANEL
4.3.4 LIPID PANEL
4.3.5 RENAL PANEL
4.3.6 THYROID FUNCTION PANEL
4.3.7 SPECIALTY CHEMICAL TESTS
4.4 MOLECULAR DIAGNOSTICS
4.4.1 PCR (POLYMERASE CHAIN REACTION)
4.4.2 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY
4.4.3 MICROARRAY
4.4.4 HYBRIDIZATION
4.4.5 DNA SEQUENCING AND NEXT GENERATION SEQUENCING (NGS)
4.4.6 OTHER MDX TECHNOLOGIES
4.5 CLINICAL MICROBIOLOGY
4.6 HEMATOLOGY
4.7 COAGULATION AND HEMOSTASIS
4.8 OTHER IVD TECHNOLOGIES
5 IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 ONCOLOGY
5.3 DIABETES
5.4 INFECTIOUS DISEASES
5.5 GENETIC TESTING
5.6 CARDIOLOGY
5.7 AUTOIMMUNE DISEASES
5.8 DRUG TESTING
5.9 NEPHROLOGY
5.10 TRANSPLANTATION TECHNOLOGY
5.11 OTHERS
6 IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 INSTRUMENTS
6.3 REAGENTS
6.4 SOFTWARES AND SERVICES
7 IN-VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE
7.1 INTRODUCTION
7.2 BLOOD
7.3 SALIVA
7.4 URINE
7.5 OTHERS
8 IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY END USER
8.1 INTRODUCTION
8.2 DIAGNOSTIC LABORATORIES
8.3 HOSPITALS
8.4 ACADEMIC & RESEARCH CENTRES
8.5 HOME CARE
8.6 OTHER END USERS
9 REGIONAL MARKET ANALYSIS
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 OTHERS
9.3 EUROPE
9.3.1 GERMANY
9.3.2 ITALY
9.3.3 FRANCE
9.3.4 OTHERS
9.4 ASIA PACIFIC
9.4.1 INDIA
9.4.2 CHINA
9.4.3 JAPAN
9.4.4 OTHERS
9.5 REST OF THE WORLD
9.5.1 BRAZIL
9.5.2 REST OF LATIN AMERICA
9.5.3 MIDDLE EAST AND OTHERS
10 COMPANY DEVELOPMENTS
10.1 INTRODUCTION
10.1.1 REGULATORY APPROVAL AS A MAJOR GROWTH STRATEGY OF
IN-VITRO DIAGNOSTICS MARKET PLAYERS
10.2 APPROVAL
10.3 NEW PRODUCT LAUNCH
10.4 AGREEMENTS PARTERNER SHIPS, COLLABORATIONS &
JOINT VENTURES
10.5 MERGERS AND ACQUISITIONS
10.6 BUSINESS EXPANSION
11 COMPANY PROFILES
11.1 ABBOTT LABORATORIES
11.1.1 OVERVIEW
11.1.2 FINANCIALS
11.1.3 PRODUCT PORTFOLIO
11.1.4 KEY DEVELOPMENTS
11.1.5 BUSINESS STRATEGY
11.1.6 SWOT ANALYSIS
11.2 BECTON DICKINSON AND COMPANY
11.2.1 OVERVIEW
11.2.2 FINANCIALS
11.2.3 PRODUCT PORTFOLIO
11.2.4 KEY DEVELOPMENTS
11.2.5 BUSINESS STRATEGY
11.2.6 SWOT ANALYSIS
11.3 BIOMERIEUX
11.3.1 OVERVIEW
11.3.2 FINANCIALS
11.3.3 PRODUCT PORTFOLIO
11.3.4 KEY DEVELOPMENTS
11.3.5 BUSINESS STRATEGY
11.3.6 SWOT ANALYSIS
11.4 BIO-RAD LABORATORIES
11.4.1 OVERVIEW
11.4.2 FINANCIALS
11.4.3 PRODUCT PORTFOLIO
11.4.4 KEY DEVELOPMENTS
11.4.5 BUSINESS STRATEGY
11.4.6 SWOT ANALYSIS
11.5 CARLYLE GROUP (ORTHO CLINICAL DIAGNOSTICS)
11.5.1 OVERVIEW
11.5.2 FINANCIALS
11.5.3 PRODUCT PORTFOLIO
11.5.4 KEY DEVELOPMENTS
11.5.5 BUSINESS STRATEGY
11.5.6 SWOT ANALYSIS
11.6 DANAHER CORPORATION
11.6.1 OVERVIEW
11.6.2 FINANCIALS
11.6.3 PRODUCT PORTFOLIO
11.6.4 KEY DEVELOPMENTS
11.6.5 BUSINESS STRATEGY
11.6.6 SWOT ANALYSIS
11.7 JOHNSON & JOHNSON
11.7.1 OVERVIEW
11.7.2 FINANCIALS
11.7.3 PRODUCT PORTFOLIO
11.7.4 KEY DEVELOPMENTS
11.7.5 BUSINESS STRATEGY
11.7.6 SWOT ANALYSIS
11.8 ROCHE HOLDINGS AG
11.8.1 OVERVIEW
11.8.2 FINANCIALS
11.8.3 PRODUCT PORTFOLIO
11.8.4 KEY DEVELOPMENTS
11.8.5 BUSINESS STRATEGY
11.8.6 SWOT ANALYSIS
11.9 SIEMENS AG
11.9.1 OVERVIEW
11.9.2 FINANCIALS
11.9.3 PRODUCT PORTFOLIO
11.9.4 KEY DEVELOPMENTS
11.9.5 BUSINESS STRATEGY
11.9.6 SWOT ANALYSIS
11.10 SYSMEX CORPORATION (SYSMEX INOSTICS)
11.10.1 OVERVIEW
11.10.2 FINANCIALS
11.10.3 PRODUCT DESCRIPTION
11.10.4 KEY DEVELOPMENTS
11.10.5 BUSINESS STRATEGY
11.10.6 SWOT ANALYSIS
11.11 THERMOFISHER SCIENTIFIC INC.
11.11.1 OVERVIEW
11.11.2 FINANCIALS
11.11.3 PRODUCT PORTFOLIO
11.11.4 KEY DEVELOPMENTS
11.11.5 BUSINESS STRATEGY
11.11.6 SWOT ANALYSIS
LIST OF TABLES
TABLE 1 IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 2 IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY TECHNOLOGY (2015-2023) ($MN)
TABLE 3 IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY APPLICATIONS (2015-2023) ($MN)
TABLE 4 IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY PRODUCT (2015-2023) ($MN)
TABLE 5 IN-VITO DIAGNOSTICS GLOBAL MARKET REVENUE, BY SAMPLE TYPES, (2015-2023) ($MN)
TABLE 6 IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
TABLE 7 IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY TECHNOLOGY (2015-2023) ($MN)
TABLE 8 IMMUNOCHEMISTRY IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 9 IMMUNOCHEMISTRY IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY TYPE (2015-2023) ($MN)
TABLE 10 ENZYME-LINKED IMMUNOSORBENT ASSAY TECHNOLOGY OF IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 11 RADIOIMMUNOASSAY (RIA) IN IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY REGION (2015-2023) ($MN)
TABLE 12 ENZYME-LINKED IMMUNOSPOT (ELISPOT) ASSAY IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY REGION (2015-2023) ($MN)
TABLE 13 RAPID TESTS IN-VITRO DIAGNOSTICS GLOBAL MARKET,
BY REGION (2015-2023) ($MN)
TABLE 14 OTHER IMMUNOASSAYS IN-VITRO DIAGNOSTICS GLOBAL MARKET,
BY REGION (2015-2023) ($MN)
TABLE 15 CLINICAL CHEMISTRY IN IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY REGION (2015-2023) ($MN)
TABLE 16 CLINICAL CHEMISTRY IN-VITRO DIAGNOSTICS GLOBAL MARKET,BY TYPE (2015-2023) ($MN)
TABLE 17 BASIC METABOLIC PROFILE IN IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 18 ELECTROLYTE PANEL IN IN-VITRO DIAGNOSTICS REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 19 LIVER PANEL IN IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 20 LIPID PANEL IN IN-VITRO DIAGNOSTIC GLOBAL MARKET, BY REGION (2015-2023) ($MN)
TABLE 21 RENAL PROFILE IN IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY REGION (2015-2023) ($MN)
TABLE 22 THYROID FUNCTION PANEL IN INVITRO DIAGNOSTICS GLOBAL MARKET, BY REGION (2015-2023) ($MN)
TABLE 23 SPECIALTY CHEMICAL TEST IN IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY REGION(2015-2023) ($MN)
TABLE 24 MOLECULAR DIAGNOSTICS IN IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 25 MOLECULAR DIAGNOSTICS MARKET REVENUE, BY TYPES, (2015-2023) ($MN)
TABLE 26 PCR TECHNIQUE IN IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 27 INAAT TECHNIQUE IN IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 28 MICROARRAY TECHNIQUE IN IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 29 HYBRIDIZATION TECHNIQUE IN IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 30 DNA SEQUENCING AND NGS TECHNIQUE IN IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 31 OTHER MDX TECHNIQUES IN IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 32 CLINICAL MICROBIOLOGY TECHNIQUE IN IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 33 HEMATOLOGY TECHNIQUE IN IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 34 COAGULATION AND HEMOSTASIS TECHNIQUE IN IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 35 OTHER IVD TECHNIQUES IN IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 36 IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY APPLICATIONS (2015-2023) ($MN)
TABLE 37 ONCOLOGY IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 38 DIABETES IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 39 INFECTIOUS DISEASE IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 40 GENETIC TESTING IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 41 CARDIOLOGY IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 42 AUTOIMMUNE DISEASES IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 43 DRUG TESTING IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 44 NEPHROLOGY IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 45 TRANSPLANTATION TECHNOLOGY IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 46 OTHER APPLICATIONS IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 47 IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY PRODUCT TYPE (2015-2023) ($MN)
TABLE 48 IN-VITRO DIAGNOSTICS INSTRUMENTS GLOBAL MARKET, BY REGION (2015-2023) ($MN)
TABLE 49 IN-VITRO DIAGNOSTICS REAGENTS GLOBAL MARKET, BY REGION, (2015-2023) ($MN)
TABLE 50 IN-VITRO DIAGNOSTICS SOFTWARE AND SERVICES GLOBAL MARKET, BY REGION (2015-2023) ($MN)
TABLE 51 IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY SAMPLE TYPE (2015-2023) ($MN)
TABLE 52 BLOOD SAMPLE TYPE IN IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 53 SALIVA SAMPLE TYPE IN IN-VITO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 54 URINE SAMPLE TYPE IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 55 OTHER SAMPLE TYPE IN-VITO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 56 IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE,
BY END-USERS, (2015-2023) ($MN)
TABLE 57 DIAGNOSTIC LABORATORIES IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 58 HOSPITALS IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 59 ACEDEMICS AND RESEARCH CENTRES IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 60 HOME CARE IN-VITO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 61 OTHER END USERS IN-VITO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 62 IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 63 NORTH AMERICAN IN-VITRO DIAGNOSTICS MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
TABLE 64 NORTH AMERICAN IN-VITRO DIAGNOSTICS MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
TABLE 65 NORTH AMERICAN IN-VITRO DIAGNOSTICS MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
TABLE 66 NORTH AMERICAN IN-VITRO DIAGNOSTICS MARKET REVENUE, BY SAMPLE TYPE, (2015-2023) ($MN)
TABLE 67 NORTH AMERICAN IN-VITRO DIAGNOSTICS MARKET REVENUE, BY END USERS, (2015-2023) ($MN)
TABLE 68 NORTH AMERICAN IN-VITRO DIAGNOSTICS MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 69 EUROPE IN-VITRO DIAGNOSTICS MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
TABLE 70 EUROPE IN-VITRO DIAGNOSTICS MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
TABLE 71 EUROPE IN-VITRO DIAGNOSTICS MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
TABLE 72 EUROPE IN-VITRO DIAGNOSTICS MARKET REVENUE, BY SAMPLE TYPE, (2015-2023) ($MN)
TABLE 73 EUROPE IN-VITRO DIAGNOSTICS MARKET REVENUE, BY END USERS, (2015-2023) ($MN)
TABLE 74 EUROPE IN-VITRO DIAGNOSTICS MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 75 ASIA PACIFIC IN-VITRO DIAGNOSTICS MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
TABLE 76 ASIA PACIFIC IN-VITRO DIAGNOSTICS MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
TABLE 77 ASIA PACIFIC IN-VITRO DIAGNOSTICS MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
TABLE 78 ASIA PACIFIC IN-VITRO DIAGNOSTICS MARKET REVENUE, BY SAMPLE TYPE, (2015-2023) ($MN)
TABLE 79 ASIA PACIFIC IN-VITRO DIAGNOSTICS MARKET REVENUE, BY END USERS, (2015-2023) ($MN)
TABLE 80 ASIA PACIFIC IN-VITRO DIAGNOSTICS MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 81 ROW IN-VITRO DIAGNOSTICS MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
TABLE 82 ROW IN-VITRO DIAGNOSTICS MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
TABLE 83 ROW IN-VITRO DIAGNOSTICS MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
TABLE 84 ROW IN-VITRO DIAGNOSTICS MARKET REVENUE, BY SAMPLE TYPE, (2015-2023) ($MN)
TABLE 85 ROW IN-VITRO DIAGNOSTICS MARKET REVENUE, BY END USERS, (2015-2023) ($MN)
TABLE 86 ROW IN-VITRO DIAGNOSTICS MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 87 APPROVALS (2015-2016)
TABLE 88 NEW PRODUCT LAUNCH (2015-2016)
TABLE 89 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2015-2016)
TABLE 90 MERGERS AND ACQUITIONS (2015-2016)
TABLE 91 BUSINESS EXPANSION (2015-2016)
TABLE 92 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 93 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 94 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
TABLE 95 BECTON DICKINSON AND COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 96 BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 97 BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY LIFE SCIENCE SEGMENTS, (2014-2016) ($MN)
TABLE 98 BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
TABLE 99 BIOMERIEUX: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 100 BIOMERIEUX: TOTAL REVENUE,BY SEGMENTS, (2014-2016) ($MN)
TABLE 101 BIOMEREIUX: TOTAL REVENUE, BY CLINICAL SEGMENTS, (2014-2016) ($MN)
TABLE 102 BIOMEREIUX: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016*) ($MN)
TABLE 103 BIO-RAD LABORATORIES: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
TABLE 104 BIO-RAD LABORATORIES: TOTAL REVENUE BY SEGMENTS, (2014-2016) ($MN)
TABLE 105 BIO-RAD LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
TABLE 106 DANAHER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 107 DANAHER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 108 DANAHER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
TABLE 109 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 110 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 111 JOHNSON & JOHNSON: TOTAL REVENUE, BY MEDICAL DEVICE SEGMENTS, (2014-2016) ($MN)
TABLE 112 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
TABLE 113 ROCHE HOLDINGS AG: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 114 ROCHE HOLDINGS AG: TOTAL REVENUE BY SEGMENTS, (2014-2016) ($MN)
TABLE 115 ROCHE HOLDINGS AG: DIAGNOSTICS REVENUE BY TYPES, (2014-2016) ($MN)
TABLE 116 ROCHE HOLDINGS AG: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
TABLE 117 SIEMENS AG: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 118 SIEMENS AG: TOTAL REVENUE, BY SEGMENT, (2014-2016) ($MN)
TABLE 119 SIEMENS AG : TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
TABLE 120 SYSMEX CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 121 SYSMEX CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 122 SYSMEX CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 123 SYSMEX CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
TABLE 124 THERMOFISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY SEGMENTS,
TABLE 125 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 126 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
LIST OF FIGURES
FIGURE 1 IN-VITRO DIAGNOSTICS GLOBAL MARKET SHARE, BY GEOGRAPHY (2015-2023)
FIGURE 2 RESEARCH METHODOLOGY: IN-VITRO DIAGNOTRICS GLOBAL MARKET
FIGURE 3 IN-VITRO DIAGNOSTIC GLOBAL MARKET: TOP-DOWN AND
BOTTOM-UP APPROACH
FIGURE 4 IN-VITRO DIAGNOSTICS GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 IN-VITRO DIAGNOSTICS GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 IVD MARKET: MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 IN-VITRO DIAGNOSTICS GLOBAL MARKET: PORTER’S ANALYSIS
FIGURE 9 IN-VITRO DIAGNOSTICS GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 10 IN-VITRO DIAGNOSTICS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
FIGURE 11 IMMUNOASSAY IN-VITRO DIAGNOSTICS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
FIGURE 12 CLINICAL CHEMISTRY IN-VITRO DIAGNOSTICS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
FIGURE 13 MOLECULAR DIAGNOSTICS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
FIGURE 14 CLINICAL MICROBIOLOGY IN-VITRO DIAGNOSTICS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
FIGURE 15 HEMATOLOGY IN-VITRO DIAGNOSTICS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
FIGURE 16 COAGULATION AND HEMOSTASIS IN-VITRO DIAGNOSTICS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
FIGURE 17 IN-VITRO DIAGNOSTICS GLOBAL MARKET SHARE, BY TECHNOLOGY, (2016 V’S 2023)
FIGURE 18 IMMUNOCHEMISTRY IN-VITRO DIAGNOSTICS MARKET SHARE, BY TYPE (2016 V’S 2023) (%)
FIGURE 19 CLINICAL CHEMISTRY IN-VITRO DIAGNOSTICS MARKET SHARE, BY TYPE (2016 V’S 2023) (%)
FIGURE 20 MOLECULAR DIAGNOSTICS IN-VITRO DIAGNOSTICS MARKET SHARE, BY TYPE (2016 V’S 2023) (%)
FIGURE 21 IN-VITRO DIAGNOSTICS GLOBAL MARKET SHARE, BY APPLICATIONS (2016 V’S 2023) (%)
FIGURE 22 IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY PRODUCTS,(2015-2023) ($MN)
FIGURE 23 IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY SAMPLE TYPE, 2016 ($MN)
FIGURE 24 IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY END USERS (2016 V’S 2023) ($MN)
FIGURE 25 IN-VITRO DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN), CAGR (%)
FIGURE 26 OUTLOOK OF NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY (2016 V’S 2023) ($MN)
FIGURE 27 OUTLOOK OF NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATIONS (2016 V’S 2023) ($MN)
FIGURE 28 OUTLOOK OF NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE, PRODUCTS AND END USERS (2016 V’S 2023) ($MN)
FIGURE 29 OUTLOOK OF U.S. IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, APPLICATION (2016 V’S 2023) ($MN)
FIGURE 30 OUTLOOK OF U.S. IN-VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE, PRODUCTS AND END USERS (2016 V’S 2023) ($MN)
FIGURE 31 OUTLOOK OF OTHER NORTH AMERICAN IN-VITRO DIAGNOSTICS MARKET, BY APPLICATIONS, TECHNIQUES (2016 V’S 2023) ($MN)
FIGURE 32 OUTLOOK OF OTHER NORTH AMERICAN IN-VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE, PRODUCTS AND END USERS (2016 V’S 2023) ($MN)
FIGURE 33 OUTLOOK OF EUROPE IN-VITRO DIAGNOSTICS MARKET SHARE, BY TECHNOLOGY (2016 V’S 2023) ($MN)
FIGURE 34 OUTLOOK OF EUROPE IN-VITRO DIAGNOSTICS MARKET SHARE, BY APPLICATION (2016 V’S 2023) ($MN)
FIGURE 35 OUTLOOK OF EUROPE IN-VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE, PRODUCTS AND END USERS (2016 V’S 2023) ($MN)
FIGURE 36 OUTLOOK OF GERMANY IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, & APPLICATION (2016 V’S 2023) ($MN)
FIGURE 37 OUTLOOK OF GERMANY IN-VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE, PRODUCTS & END USERS (2016 V’S 2023) ($MN)
FIGURE 38 OUTLOOK OF ITALY IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, APPLICATION (2016 V’S 2023) ($MN)
FIGURE 39 OUTLOOK OF ITALY IN-VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE, PRODUCTS & END USERS (2016 V’S 2023) ($MN)
FIGURE 40 OUTLOOK OF FRANCE IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, & APPLICATION (2016 V’S 2023) ($MN)
FIGURE 41 OUTLOOK OF FRANCE IN-VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE, PRODUCTS & END USERS (2016 V’S 2023) ($MN)
FIGURE 42 OUTLOOK OF OTHER EUROPEAN IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, & APPLICATIONS (2016 V’S 2023) ($MN)
FIGURE 43 OUTLOOK OF OTHER EUROPEAN IN-VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE, PRODUCTS & END-USERS (2016 V’S 2023) ($MN)
FIGURE 44 OUTLOOK OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SHARE, BY TECHNOLOGY (2016 V’S 2023) ($MN)
FIGURE 45 OUTLOOK OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SHARE, BY APPLICATION (2016 V’S 2023) ($MN)
FIGURE 46 OUTLOOK OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE, PRODUCTS & END USERS (2016 V’S 2023) ($MN)
FIGURE 47 OUTLOOK OF INDIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY & APPLICATION (2016 V’S 2023) ($MN)
FIGURE 48 OUTLOOK OF INDIA IN-VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE, PRODUCTS & END USERS (2016 V’S 2023) ($MN)
FIGURE 49 OUTLOOK OF CHINA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, & APPLICATION (2016 V’S 2023) ($MN)
FIGURE 50 OUTLOOK OF CHINA IN-VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE, PRODUCTS & END USERS (2016 V’S 2023) ($MN)
FIGURE 51 OUTLOOK OF JAPAN IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, & APPLICATION (2016 V’S 2023) ($MN)
FIGURE 52 OUTLOOK OF JAPAN IN-VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE, PRODUCTS & END USERS (2016 V’S 2023) ($MN)
FIGURE 53 OUTLOOK OF OTHER ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, APPLICATIONS & END-USERS (2016 V’S 2023) ($MN)
FIGURE 54 OUTLOOK OF OTHER ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE, PRODUCTS & END-USERS (2016 V’S 2023) ($MN)
FIGURE 55 OUTLOOK OF ROW IN-VITRO DIAGNOSTICS MARKET SHARE, BY TECHNOLOGY (2016 V’S 2023) ($MN)
FIGURE 56 OUTLOOK OF ROW IN-VITRO DIAGNOSTICS MARKET SHARE, BY APPLICATIONS (2016 V’S 2023) ($MN)
FIGURE 57 OUTLOOK OF ROW IN-VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE, PRODUCTS & END-USERS (2016 V’S 2023) ($MN)
FIGURE 58 OUTLOOK OF BRAZIL IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, & APPLICATION (2016 V’S 2023) ($MN)
FIGURE 59 OUTLOOK OF BRAZIL IN-VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE, PRODUCTS & END USERS (2016 V’S 2023) ($MN)
FIGURE 60 OUTLOOK OF REST OF LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, & APPLICATION (2016 V’S 2023) ($MN)
FIGURE 61 OUTLOOK OF REST OF LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE, PRODUCTS & END USERS (2016 V’S 2023) ($MN)
FIGURE 62 OUTLOOK OF MIDDLE EAST AND OTHERS IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, & APPLICATION (2016 V’S 2023) ($MN)
FIGURE 63 OUTLOOK OF MIDDLE EAST AND OTHERS IN-VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE, PRODUCTS & END USERS (2016 V’S 2023) ($MN)
FIGURE 64 KEY GROWTH STRATEGIES (2015-2016)
FIGURE 65 SWOT: ABBOTT LABORATORIES
FIGURE 66 SWOT: BECTON DICKINSON AND COMPANY
FIGURE 67 SWOT: BIOMEREIUX
FIGURE 68 SWOT: BIO-RAD LABORATORIES
FIGURE 69 SWOT: CARLYLE GROUP (ORTHO CLINICAL DIAGNOSTIC)
FIGURE 70 SWOT: DANAHER CORPORATION
FIGURE 71 SWOT: JOHNSON & JOHNSON
FIGURE 72 SWOT: HOFFMANN LA ROCHE
FIGURE 73 SWOT: SIEMENS AG
FIGURE 74 SWOT: SYSMEX CORPORATION
FIGURE 75 SWOT:THERMOFISHER SCIENTIFIC

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report